Posts

Call for Group Pass: Save More When You Attend Together

Image
16th Emirates Pathology, Digital Pathology, Cancer Conference and Exhibition April 09–11, 2026 | Dubai, UAE In today’s rapidly evolving healthcare landscape, collaboration, shared learning, and interdisciplinary engagement are more important than ever. Recognizing the value of collective participation, the 16th Emirates Pathology, Digital Pathology, Cancer Conference & Exhibition is pleased to introduce a special Group Pass , designed to make global knowledge exchange more accessible, affordable, and impactful for institutions and organizations. Scheduled to take place from April 09–11, 2026, in Dubai, UAE , this internationally recognized conference will bring together leaders and professionals from pathology, oncology, laboratory medicine, digital diagnostics, research, and healthcare innovation. The Group Pass , available at a highly discounted rate of GBP 1000 for five (5) delegates , offers an exceptional opportunity for teams to attend together, save more, and gain collectiv...

Slots Are Available: Book Your Participation at the 16th Emirates Pathology, Digital Pathology & Cancer Conference Today

Image
  The field of pathology is evolving at an unprecedented pace, driven by rapid technological advancements, digital transformation, and groundbreaking discoveries in cancer research and laboratory medicine. In this dynamic landscape, continuous learning, collaboration, and global knowledge exchange are more important than ever. Keeping this in mind, the 16th Emirates Pathology, Digital Pathology, Cancer Conference & Exhibition is set to bring together the world’s leading minds in pathology and allied disciplines for an impactful scientific gathering. Scheduled to take place from April 09–11, 2026, in Dubai, United Arab Emirates , this prestigious international conference offers an exceptional platform for pathologists, oncologists, laboratory medicine professionals, researchers, academicians, clinicians, and industry experts to connect, collaborate, and contribute to the future of diagnostic and cancer sciences. A Distinguished Global Forum for Pathology and Cancer Research Ove...

Dr. Matus Coma: Advancing Therapeutic Strategies in Pancreatic Cancer Research

Image
Dr. Matus Coma is a distinguished scientist from Slovakia, recognized for his impactful contributions to pharmacological research and cancer therapeutics. He will be a featured presenter at the 16th Emirates Pathology, Digital Pathology, Cancer Conference & Exhibition , a premier global forum that brings together leading experts in pathology, oncology, and biomedical research. Dr. Coma currently serves as a Leading Scientist in the Department of Pharmacology, Medical Faculty, Pavol Jozef Safarik University , where his research focuses on improving treatment outcomes through innovative drug-based strategies. Dr. Coma will present a poster titled “ Tigecycline Enhances the Cytotoxic Efficacy of FOLFIRINOX and Gem-Pac in Pancreatic Ductal Adenocarcinoma Cell Models ” at the conference. This study explores novel therapeutic combinations aimed at enhancing the effectiveness of standard chemotherapy regimens for pancreatic ductal adenocarcinoma—one of the most aggressive and treatment-r...